| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12640-017-9767-0 |
| P698 | PubMed publication ID | 28656547 |
| P50 | author | Aline Longoni | Q47503683 |
| P2093 | author name string | Angela T S Wyse | |
| Cassiana Siebert | |||
| Janaína Kolling | |||
| Tiago Marcon Dos Santos | |||
| Lenir Orlandi Pereira | |||
| Eduardo Peil Marques | |||
| Jaqueline Carletti | |||
| P2860 | cites work | Homocysteine contribution to DNA damage in cystathionine β-synthase-deficient patients | Q24337464 |
| Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis | Q24527330 | ||
| Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value? | Q24631151 | ||
| Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study | Q24658404 | ||
| Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation | Q28216292 | ||
| Regulation of sodium-calcium exchanger activity by creatine kinase under energy-compromised conditions. | Q33615575 | ||
| Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases | Q33917550 | ||
| Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? | Q34666769 | ||
| Clinical use of creatine in neuromuscular and neurometabolic disorders | Q34800131 | ||
| The methionine-homocysteine cycle and its effects on cognitive diseases | Q35075332 | ||
| Glucocorticoid effects on object recognition memory require training-associated emotional arousal | Q35554524 | ||
| Regulation of apoptosis by endoplasmic reticulum pathways. | Q35591699 | ||
| High homocysteine induces betaine depletion | Q36185101 | ||
| Interrogating rodents regarding their object and spatial memory. | Q36252630 | ||
| Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia | Q36477209 | ||
| The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases | Q37027534 | ||
| Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction | Q37104293 | ||
| Functions and effects of creatine in the central nervous system. | Q37172733 | ||
| Neuroprotective effects of creatine | Q37859313 | ||
| In sickness and in health: the widespread application of creatine supplementation. | Q37958749 | ||
| Homocysteine and the pathogenesis of atherosclerosis | Q38344699 | ||
| Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression | Q38588007 | ||
| Creatine for neuroprotection in neurodegenerative disease: end of story? | Q38691246 | ||
| Homocysteine enhances MMP-9 production in murine macrophages via ERK and Akt signaling pathways | Q39397807 | ||
| Folate deprivation increases tau phosphorylation by homocysteine-induced calcium influx and by inhibition of phosphatase activity: Alleviation by S-adenosyl methionine | Q40012552 | ||
| Molecular and biochemical investigations of patients with intermediate or severe hyperhomocysteinemia | Q40988012 | ||
| Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction | Q41689199 | ||
| Hyperhomocysteinemia Association With Transient Global Amnesia: A Rare Case Report | Q42104150 | ||
| Dihydrotestosterone modulates spatial working-memory performance in male mice | Q42621782 | ||
| Creatine prevents the inhibition of energy metabolism and lipid peroxidation in rats subjected to GAA administration. | Q42911287 | ||
| Curcumin exerts neuroprotective effects against homocysteine intracerebroventricular injection-induced cognitive impairment and oxidative stress in rat brain | Q43018815 | ||
| Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension | Q43107052 | ||
| Direct antioxidant properties of creatine | Q43846466 | ||
| On the mechanism of the inhibition of Na(+), K(+)-ATPase activity caused by homocysteine. | Q44008826 | ||
| Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage | Q44211456 | ||
| Impairment of energy metabolism in hippocampus of rats subjected to chemically-induced hyperhomocysteinemia | Q44404792 | ||
| Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria | Q44487554 | ||
| Creatine prevents the imbalance of redox homeostasis caused by homocysteine in skeletal muscle of rats. | Q44701693 | ||
| Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task. | Q44987144 | ||
| Enhanced hippocampal long-term potentiation in rats after chronic exposure to homocysteine | Q45165122 | ||
| Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats | Q45210504 | ||
| Acute homocysteine administration impairs memory consolidation on inhibitory avoidance task and decreases hippocampal brain-derived neurotrophic factor immunocontent: prevention by folic acid treatment. | Q45924861 | ||
| Long-term creatine supplementation is safe in aged patients with Parkinson disease. | Q46197864 | ||
| Long-term effects of corticosterone on behavior, oxidative and energy metabolism of parietotemporal cerebral cortex and hippocampus of rats: comparison to intracerebroventricular streptozotocin | Q46446421 | ||
| Homocysteine induces energy imbalance in rat skeletal muscle: is creatine a protector? | Q46463747 | ||
| Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease | Q46493551 | ||
| d-galactose administration induces memory loss and energy metabolism disturbance in mice: protective effects of catalpol | Q46523717 | ||
| Neuroprotection and mechanisms of atractylenolide III in preventing learning and memory impairment induced by chronic high-dose homocysteine administration in rats | Q46775414 | ||
| Are the consequences of neonatal hypoxia-ischemia dependent on animals' sex and brain lateralization? | Q46841758 | ||
| Creatine prevents behavioral alterations caused by methylmalonic acid administration into the hippocampus of rats in the open field task | Q46927167 | ||
| Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity | Q46977833 | ||
| Intracerebroventricular D-galactose administration impairs memory and alters activity and expression of acetylcholinesterase in the rat. | Q47444963 | ||
| Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex | Q48137136 | ||
| Lateralized and sex-dependent behavioral and morphological effects of unilateral neonatal cerebral hypoxia-ischemia in the rat. | Q48307253 | ||
| Neonatal cerebral hypoxia–ischemia causes lateralized memory impairments in the adult rat | Q48315395 | ||
| Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial | Q48400110 | ||
| Effects of daily environmental enrichment on memory deficits and brain injury following neonatal hypoxia-ischemia in the rat. | Q48433969 | ||
| Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats. | Q48578754 | ||
| Severe Hyperhomocysteinemia Decreases Respiratory Enzyme and Na(+)-K(+) ATPase Activities, and Leads to Mitochondrial Alterations in Rat Amygdala | Q49114250 | ||
| Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients. | Q51381399 | ||
| Interaction between consecutive learnings: inhibitory avoidance and habituation. | Q52204621 | ||
| Chronic hyperhomocysteinemia induces oxidative damage in the rat lung. | Q52613124 | ||
| [Brain isoforms of creatine kinase in health and mental diseases: Alzheimer's disease and schizophrenia]. | Q53333970 | ||
| Creatine supplementation does not augment muscle carnosine content in type 2 diabetic patients | Q57537573 | ||
| Tactile stimulation and maternal separation prevent hippocampal damage in rats submitted to neonatal hypoxia–ischemia | Q59203141 | ||
| Lipid, Oxidative and Inflammatory Profile and Alterations in the Enzymes Paraoxonase and Butyrylcholinesterase in Plasma of Patients with Homocystinuria Due CBS Deficiency: The Vitamin B12 and Folic Acid Importance | Q62168057 | ||
| A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera | Q79528423 | ||
| Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial | Q80244024 | ||
| Homocysteine alters glutamate uptake and Na+,K+-ATPase activity and oxidative status in rats hippocampus: protection by vitamin C | Q83348858 | ||
| Acute hyperhomocysteinemia alters the coagulation system and oxidative status in the blood of rats | Q84988428 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 585-593 | |
| P577 | publication date | 2017-06-27 | |
| P1433 | published in | Neurotoxicity Research | Q15764278 |
| P1476 | title | Severe Hyperhomocysteinemia Decreases Creatine Kinase Activity and Causes Memory Impairment: Neuroprotective Role of Creatine | |
| P478 | volume | 32 |
Search more.